Delivery Order SPE2DB24D2010-SPE2DB25FABJT
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors valued at $11,830.00. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to complete by September 18, 2025, with performance executed from AmerisourceBergen's Conshohocken, Pennsylvania headquarters. This delivery order...
- The Defense Logistics Agency awarded a $47,320 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of SKYRIZI 360 MG/2.4 ML on-body injectors. This firm fixed-price contract, which must be completed by September 29, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery order through its existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $23,660 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. This firm fixed price, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery order is scheduled for completion by October 9, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $11,830 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. The contract, which carries an ultimate completion date of September 29, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $23,660 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. This competitive, firm fixed-price delivery order is scheduled for completion by October 10, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of SKYRIZI 180 mg/1.2 mL on-body injectors valued at $11,830. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's broader pharmaceutical supply agreements with the federal government. The order is scheduled for completion by September 24, 2025, and will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors valued at $11,830.00 under a firm fixed price contract. The order, which is expected to be completed by September 9, 2025, will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without a set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $11,830 on September 8, 2025, for the supply of SKYRIZI 180 mg/1.2 ml on-body injectors. This firm fixed-price delivery order, with completion expected by September 29, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Skyrizi 360 mg/2.4 mL on-body injectors valued at $11,830.00, with completion expected by September 9, 2025. This is a firm fixed-price delivery order issued under a non-set-aside procurement, with performance based at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical procurement supporting the...
- The Defense Logistics Agency awarded a $11.83K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injector units. The contract is unset-aside and competitively awarded on a firm fixed-price basis, with performance originating from the company's Conshohocken, Pennsylvania facility and scheduled completion by October 8, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABJTDelivery Order
The Defense Logistics Agency awarded a $23,660 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors, with completion targeted for October 16, 2025. This competitively awarded, firm fixed-price delivery order reflects no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a specific fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The prime IDC serves as a comprehensive vehicle for supplying pharmaceuticals and medical commodities to support military healthcare systems globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen leverages its extensive portfolio to supply brand-name medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.7k | 9/24/25 |